Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study
NCT00222820 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2005-09-22
Summary
We are doing this pilot study to learn more about four aspects of treating depression:
1. The features of a depressed person's mood and anxiety and how these features affect a person's capacity to get better and stay better.
2. If depressed people with certain features of mood and anxiety respond better to therapy, medication or a combination of therapy and medication.
3. Whether or not a person's personality traits affect how they respond to treatment.
4. The gene involved in processing antidepressant medication
Conditions
Interventions
- DRUG
-
escitalopram
- BEHAVIORAL
-
Interpersonal Psychotherapy
Sponsors & Collaborators
-
Mental Health Intervention Research Center (MHIRC)
collaborator UNKNOWN -
University of Pittsburgh
lead OTHER
Principal Investigators
-
Ellen Frank, Ph.D. · University of Pittsburgh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
- Completion
- 2004-09-30
Countries
- United States
Study Locations
More Related Trials
-
Treatment Choices for Improving Adherence and Outcome
NCT00194948 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
NCT01111552 ·Status: TERMINATED ·Phase: PHASE3
-
Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression
NCT00824044 ·Status: COMPLETED ·Phase: PHASE4
-
Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder
NCT00239954 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Neural Responses Induced by Antidepressant Effects
NCT02674529 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Developing New Clinical Management Strategies
NCT02082392 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression
NCT00566202 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
NCT00252330 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder
NCT06532604 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Advancing Personalized Antidepressant Treatment Using PET/MRI
NCT02623205 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression
NCT01098240 ·Status: TERMINATED ·Phase: PHASE2
-
Combining Medications to Enhance Depression Outcomes
NCT00590863 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
NCT00109044 ·Status: COMPLETED ·Phase: PHASE3
-
Identifying Factors That Predict Antidepressant Treatment Response
NCT00360399 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
NCT02288325 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)
NCT00035282 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression
NCT00070694 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
NCT01111539 ·Status: TERMINATED ·Phase: PHASE3
-
AZD7268 Safety and Tolerability Study
NCT01020799 ·Status: COMPLETED ·Phase: PHASE2
-
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
NCT00810069 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication
NCT04937829 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)
NCT05203341 ·Status: COMPLETED ·Phase: PHASE2
-
Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder
NCT01598324 ·Status: TERMINATED
-
Neurotrophic Factors and Depression
NCT00812994 ·Status: COMPLETED ·Phase: PHASE4
-
Imaging Predictors of Treatment Response in Depression
NCT00367341 ·Status: COMPLETED ·Phase: NA